NCT07243470
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07243470
Title Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors (TARLATEM)
Acronym TARLATEM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries FRA